Search for Clinical Trial Results

Sponsored By

Neurotoxicity Syndromes - 25 Studies Found

Status Study
Terminated Study Name: A Pilot Study of Dextromethorphan for the Prevention and Treatment of Methotrexate Neurotoxicity
Condition: Neurotoxicity Syndromes
Date: 2005-09-12
Interventions: Drug: Dextromethorphan Patients will receive an inert carrier with or without dextromethorphan. The stud
Recruiting Study Name: To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity
Condition: Neurotoxicity Syndromes
Date: 2015-06-09
Interventions:
  • Other: Questionnaires EORTC CI
Recruiting Study Name: Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients
Condition: Neurotoxicity
Date: 2015-07-11
Interventions: Drug: monosialoganglioside 40mg in the vein on day 1 - day 8 of each 21 days cycle. Number of Cycles: 2
Terminated Study Name: Study to Assess Prevention of Oxaliplatin-induced Neurotoxicity Through Vitamin D Pathway
Condition: Neurotoxicity
Date: 2011-10-18
Interventions: Drug: Vitamin D3 Vitamin D3 will be administered at a dose of 2000 IU orally daily starting on day 1 of
Recruiting Study Name: Monosialotetrahexosylganglioside for Treatment of Oxaliplatin Induced Neurotoxicity in Gastrointestinal Cancer
Condition: Neurotoxicity
Date: 2015-05-03
Interventions:
  • Drug: placebo

Completed Study Name: Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity
Condition:
  • Neurotoxic Disorders
  • Cancer

Date: 2008-07-31
Interventions: Drug: Mangafodipir Mangafodipir (0.5 ml/kg) is administered as a 30 minutes infusion just after each adm
Completed Study Name: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery
Condition:
  • Colorectal Cancer
  • Neurotoxicity

Date: 2006-04-19
Interventions:
  • Drug: calcium gluconate Given

Completed Study Name: Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin
Condition:
  • Chemotherapeutic Agent Toxicity
  • Colorectal Cancer
  • Date: 2009-04-18
    Interventions:
    • Drug: FOLFOX regimen
    • Drug: fluorouracil
Withdrawn Study Name: Scopolamine Treatment for Patients With Organophosphate Poisoning
Condition: Neurotoxicity Syndromes
Date: 2006-10-17
Interventions: Drug: Placebo IV placebo q4h
Completed Study Name: Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
Condition:
  • Chemotherapeutic Agent Toxicity
  • Colorectal Cancer
  • Neuropat
    Date: 2010-04-06
    Interventions:
    • Drug: calcium gluconate Given

Next >>>